Italian guidelines on thrombolysis indications in ischemic stroke have been revised after IST-3 trial and Cochrane revision: cons.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Critical early thrombolytic and endovascular reperfusion therapy for acute ischemic stroke victims: a call for adjunct neuroprotection.Translational stroke research · 2015
   Article
2. Safety and feasibility of intravenous rt-PA in the Emergency Department without a neurologist-based stroke unit: an observational study.Internal and emergency medicine · 2015
   Observational
3. Safety and efficacy even after 90 years of age should prompt removal of upper age limits in systemic thrombolysis for stroke.Internal and emergency medicine · 2014
   Article
4. Thrombolysis in the elderly: yes but with caution.Internal and emergency medicine · 2014
   Article
5. Italian guidelines on thrombolysis indications in ischemic stroke have been revised after the IST-3 trial and Cochrane review.Internal and emergency medicine · 2014
   Article
6. Fast neuroprotection (fast-NPRX) for acute ischemic stroke victims: the time for treatment is now.Translational stroke research · 2013
   Article

Corrections and comments

• Commented on by
  Safety and efficacy even after 90 years of age should prompt removal of upper age limits in systemic thrombolysis for stroke.2014
• Commented on by
  Thrombolysis in the elderly: yes but with caution.2014
• Commented on by
  Italian guidelines on thrombolysis indications in ischemic stroke have been revised after the IST-3 trial and Cochrane review.2014

Authors and funding

5 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as